Latest news

Today, 2:12 PM

Gainers Trillium Therapeutics Inc. (NASDAQ: TRIL) shares jumped 188.8% to close at $17.59 on Monday after the company agreed to be acquired by Pfizer for $18.50 per share, implying an equity value of $2.26 billion.

ABVC

4 minute read

46 Biggest Movers From Yesterday

Today, 2:12 PM

Gainers PharmaCyte Biotech, Inc. (NASDAQ: PMCB) shares climbed 189.5% to close at $9.90 on Wednesday after surging over 15% on Tuesday.

ABUS

3 minute read

34 Stocks Moving In Wednesday’s Mid-Day Session

Today, 2:12 PM

Gainers PharmaCyte Biotech, Inc. (NASDAQ: PMCB) shares jumped 139% to $8.18 after surging over 15% on Tuesday.

ACRX

19 minute read

Benzinga’s Top Ratings Upgrades, Downgrades For August 16, 2021

By Benzinga Insights

Today, 2:12 PM

Upgrades

ABSI

1 minute read

Morgan Stanley Initiates Coverage On Couchbase with Equal-Weight Rating, Announces Price Target of $34

Today, 2:12 PM

Morgan Stanley analyst Sanjit Singh initiates coverage on Couchbase (NASDAQ:BASE) with a Equal-Weight rating and announces Price Target of $34.

1 minute read

Stifel Initiates Coverage On Couchbase with Buy Rating, Announces Price Target of $43

Today, 2:12 PM

Stifel analyst Brad Reback initiates coverage on Couchbase (NASDAQ:BASE) with a Buy rating and announces Price Target of $43.

1 minute read

Goldman Sachs Initiates Coverage On Couchbase with Neutral Rating, Announces Price Target of $49

Today, 2:12 PM

Goldman Sachs initiates coverage on Couchbase (NASDAQ:BASE) with a Neutral rating and announces Price Target of $49.

1 minute read

RBC Capital Initiates Coverage On Couchbase with Outperform Rating, Announces Price Target of $40

Today, 2:12 PM

RBC Capital analyst Matthew Hedberg initiates coverage on Couchbase (NASDAQ:BASE) with a Outperform rating and announces Price Target of $40.

6 minute read

78 Biggest Movers From Friday